Jeremy Morgan
Director/Board Member at ARECOR THERAPEUTICS PLC
Jeremy Morgan active positions
Companies | Position | Start | End |
---|---|---|---|
ARECOR THERAPEUTICS PLC | Director/Board Member | - | - |
Independent Dir/Board Member | - | - | |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | - | - |
Career history of Jeremy Morgan
Former positions of Jeremy Morgan
Companies | Position | Start | End |
---|---|---|---|
PHMR Ltd.
PHMR Ltd. Information Technology ServicesTechnology Services Part of UDG Healthcare Ltd. (Dublin), PHMR Ltd. is a healthcare consulting British company that specializes in insight-enabled pricing and market access approaches to ensure successful product launch and life-cycle management. The private company is based in London, UK. The company helps its clients in the healthcare industries build value for their products by using academically-proven analytical methods to find and form clinical, economic, and humanistic evidence. PHMR is an international team of highly qualified health economists and research scientists. The company was founded by Mark Ratcliffe, who has been the CEO since incorporation. PHMR was acquired by UDG Healthcare Ltd. (Dublin) on January 26, 2021 for $43.75 million. | Chairman | 01/01/2019 | 01/01/2020 |
Chief Operating Officer | 01/01/2018 | 01/01/2019 | |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2014 | 01/01/2017 |
Training of Jeremy Morgan
Coventry University | Undergraduate Degree |
Statistics
International
United Kingdom | 5 |
United States | 2 |
Operational
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ARECOR THERAPEUTICS PLC | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Private companies | 2 |
---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
PHMR Ltd.
PHMR Ltd. Information Technology ServicesTechnology Services Part of UDG Healthcare Ltd. (Dublin), PHMR Ltd. is a healthcare consulting British company that specializes in insight-enabled pricing and market access approaches to ensure successful product launch and life-cycle management. The private company is based in London, UK. The company helps its clients in the healthcare industries build value for their products by using academically-proven analytical methods to find and form clinical, economic, and humanistic evidence. PHMR is an international team of highly qualified health economists and research scientists. The company was founded by Mark Ratcliffe, who has been the CEO since incorporation. PHMR was acquired by UDG Healthcare Ltd. (Dublin) on January 26, 2021 for $43.75 million. | Technology Services |
- Stock Market
- Insiders
- Jeremy Morgan
- Experience